The Burkholderia cepacia complex comprises a group of nine closely related species that have emerged as life-threatening pulmonary pathogens in immunocompromised patients, particularly individuals with cystic fibrosis or chronic granulomatous disease. Attempts to explain the genomic plasticity, adaptability and virulence of the complex have paid little attention to bacteriophages, particularly the potential contribution of lysogenic conversion and transduction. In this study, lysogeny was observed in 10 of 20 representative strains of the B. cepacia complex. Three temperate phages and five lytic phages isolated from soils, river sediments or the plant rhizosphere were chosen for further study. Six phages exhibited T-even morphology and two were lambda-like. The host range of individual phages, when tested against 66 strains of the B. cepacia complex and a representative panel of other pseudomonads, was not species-specific within the B. cepacia complex and, in some phages, included Burkholderia gladioli and Pseudomonas aeruginosa. These new data indicate a potential role for phages of the B. cepacia complex in the evolution of these soil bacteria as pathogens of plants, humans and animals, and as novel therapeutic agents.
ArisR. M,
RouthJ. C,
LiPumaJ. J,
HeathD. G,
GilliganP. H.2001; Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex.Survival linked to genomovar type. Am J Respir Crit Care Med 164:2102–2106[CrossRef]
BerriatuaE,
ZiluagaI,
Miguel-VirtoC,
UribarrenP,
JusteR,
LaevensS,
VandammeP,
GovanJ. R. W.2001; Outbreak of subclinical mastitis in a flock of dairy sheep associated with Burkholderia cepacia complex infection. J Clin Microbiol 39:990–994[CrossRef]
BevivinoA,
DalmastriC,
TabacchioniS,
ChiariniL,
BelliM. L,
PianaS,
MaterazzoA,
VandammeP,
MannoG.2002; Burkholderia cepacia complex bacteria from clinical and environmental sources in Italy: genomovar status and distribution of traits related to virulence and transmissibility. J Clin Microbiol 40:846–851[CrossRef]
CoenyeT,
VandammeP,
GovanJ. R. W,
LiPumaJ. J.2001; Taxonomy and identification of the Burkholderia cepacia complex. J Clin Microbiol 39:3427–3436[CrossRef]
FisherM. C,
LiPumaJ. J,
DasenS. E,
CaputoG. C,
MortensenJ. E,
McGowanK. L,
StullT. L.1993; Source of Pseudomonas cepacia : ribotyping of isolates from patients and from the environment. J Pediatr 123:745–747[CrossRef]
GutmannL,
AgarwalM,
ArthurM,
CampanelliC,
GoldsteinR.1990; A phasmid shuttle vector for the cloning of complex operons in Salmonella . Plasmid 23:42–58[CrossRef]
HolmesA,
GovanJ,
GoldsteinR.1998; Agricultural use of Burkholderia ( Pseudomonas ) cepacia : a threat to human health?. Emerg Infect Dis 4:221–227[CrossRef]
HolmesA,
NolanR,
TaylorR,
FinleyR,
RileyM,
JiangR.-Z,
SteinbachS,
GoldsteinR.1999; An epidemic of Burkholderia cepacia transmitted between patients with and without cystic fibrosis. J Infect Dis 179:1197–1205[CrossRef]
HughesJ. E,
StewartJ,
BarclayG. R,
GovanJ. R. W.1997; Priming of neutrophil respiratory burst activity by lipopolysaccharide from Burkholderia cepacia . Infect Immun 65:4281–4287
KennaD. T,
BarcusV. A,
LangleyR. J,
VandammeP,
GovanJ. R. W.2003; Lack of correlation between O-serotype, bacteriophage susceptibility and genomovar status in the Burkholderia cepacia complex. FEMS Immunol Med Microbiol 35:87–92[CrossRef]
LiPumaJ. J,
SpilkerT,
GillL. H,
CampbellP. WIII,
LiuL,
MahenthiralingamE.2001; Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis. Am J Respir Crit Care Med 164:92–96[CrossRef]
MackK,
TitballR. W.1998; The detection of insertion sequences within the human pathogen Burkholderia pseudomallei which have been identified previously in Burkholderia cepacia . FEMS Microbiol Lett 162:69–74[CrossRef]
NzulaS,
VandammeP,
GovanJ. R. W.2000; Sensitivity of the Burkholderia cepacia complex and Pseudomonas aeruginosa to transducing bacteriophages. FEMS Immunol Med Microbiol 28:307–312[CrossRef]
NzulaS,
VandammeP,
GovanJ. R. W.2002; Influence of taxonomic status on the in vitro antimicrobial susceptibility of the Burkholderia cepacia complex. J Antimicrob Chemother 50:265–269[CrossRef]
ParkeJ. L,
Gurian-ShermanD.2001; Diversity of the Burkholderia cepacia complex and implications for risk assessment of biological control strains. Annu Rev Phytopathol 39:225–258[CrossRef]
PittT. L,
KaufmannM. E,
PatelP. S,
BengeL. C. A,
GaskinS,
LivermoreD. M.1996; Type characterisation and antibiotic susceptibility of Burkholderia ( Pseudomonas ) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland. J Med Microbiol 44:203–210[CrossRef]
VandammeP,
HolmesB,
VancanneytM.8 other authors1997; Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp.nov. Int J Syst Bacteriol 47:1188–1200[CrossRef]
VandammeP,
HolmesB,
CoenyeT,
GorisJ,
MahenthiralingamE,
LiPumaJ. J,
GovanJ. R. W.2003; Burkholderia cenocepacia sp.nov. – a new twist to an old story. Res Microbiol 154:91–96[CrossRef]
VermisK,
VandekerckhoveC,
NelisH. J,
VandammeP. A. R.2002; Evaluation of restriction fragment length polymorphism analysis of 16S rDNA as a tool for genomovar characterisation within the Burkholderia cepacia complex. FEMS Microbiol Lett 214:1–5[CrossRef]
ViscaP,
CazzolaG,
PetruccaA,
BraggionC.2001; Travel-associated Burkholderia pseudomallei infection (melioidosis) in a patient with cystic fibrosis: a case report. Clin Infect Dis 32:E15–E16[CrossRef]
WeissB. D,
CapageM. A,
KesselM,
BensonS. A.1994; Isolation and characterization of a generalized transducing phage for Xanthomonas campestris pv. campestris . J Bacteriol 176:3354–3359
WigleyP,
BurtonN. F.2000; Multiple chromosomes in Burkholderia cepacia and B.gladioli and their distribution in clinical and environmental strains of B. cepacia . J Appl Microbiol 88:914–918[CrossRef]